Search research articles
Contact Us
Filters
Showing results (131-140 of 152) with videos related to
Page
of 16
Sort By:
Schizophrenia Research
|
September 28, 2023
Risk factors for suicidality across psychosis vulnerability spectrum
Nils Malte Stephan, Eleonore Dorothée van Sprang, Jasper Xiao Ming Wiebenga, et al.
Psychological Medicine
|
October 29, 2025
Psychological side effects of antipsychotic medication after remission from first-episode psychosis: a HAMLETT ecological momentary assessment study
Matej Djordjevic, Shiral S Gangadin, Lieuwe de Haan, et al.
Psychological Medicine
|
January 2, 2026
Negative association between cognitive functioning and antipsychotic D<sub>2</sub> receptor occupancy, affinity, and dose after first episode psychosis
Priscilla P Oomen, Shiral S Gangadin, Lieuwe de Haan, et al.
Schizophrenia Bulletin
|
July 17, 2025
The International Psychosis Epidemiology Consortium Virtual Databank-A Platform for Data Harmonization and Federated Analysis of Psychosis Cohorts
Vera Brink, Natalia Tiles-Sar, Hannah Jongsma, et al.
Psychological Medicine
|
September 8, 2025
Dopamine D<sub>2/3</sub>R availability after discontinuation of antipsychotic treatment: a [<sup>11</sup>C]raclopride PET study in remitted first-episode psychosis patients
Franciska de Beer, Erik de Vries, Ben Wijnen, et al.
Plos One
|
July 19, 2019
"Please tell me what happened": A descriptive study on prevalence, disclosure and characteristics of victimization in people with a psychotic disorder
Bertine de Vries, Gerdina H M Pijnenborg, Elisabeth C D van der Stouwe, et al.
JAMA Psychiatry
|
October 1, 2025
Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical Trial
Iris E Sommer, Franciska de Beer, Shiral Gangadin, et al.
Schizophrenia Research
|
March 20, 2026
Genetic susceptibility of cardiometabolic outcomes in schizophrenia spectrum disorders
Chenxu Zhao, Bochao Lin, Elnaz Naderi, et al.
Nature Medicine
|
August 13, 2025
Virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: a randomized controlled trial
Ulrik N Jeppesen, Ditte L Vernal, Anne Sofie Due, et al.
Pilot and Feasibility Studies
|
May 2, 2020
A cognitive remediation training for young adults with psychotic disorders to support their participation in education - study protocol for a pilot randomized controlled trial
Lana K M Otto, Jacomijn Hofstra, Michelle G Mullen, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 152) with videos related to
Sort By:
Page
of 16
Schizophrenia Research
|
September 28, 2023
Risk factors for suicidality across psychosis vulnerability spectrum
Nils Malte Stephan, Eleonore Dorothée van Sprang, Jasper Xiao Ming Wiebenga, et al.
Psychological Medicine
|
October 29, 2025
Psychological side effects of antipsychotic medication after remission from first-episode psychosis: a HAMLETT ecological momentary assessment study
Matej Djordjevic, Shiral S Gangadin, Lieuwe de Haan, et al.
Psychological Medicine
|
January 2, 2026
Negative association between cognitive functioning and antipsychotic D<sub>2</sub> receptor occupancy, affinity, and dose after first episode psychosis
Priscilla P Oomen, Shiral S Gangadin, Lieuwe de Haan, et al.
Schizophrenia Bulletin
|
July 17, 2025
The International Psychosis Epidemiology Consortium Virtual Databank-A Platform for Data Harmonization and Federated Analysis of Psychosis Cohorts
Vera Brink, Natalia Tiles-Sar, Hannah Jongsma, et al.
Psychological Medicine
|
September 8, 2025
Dopamine D<sub>2/3</sub>R availability after discontinuation of antipsychotic treatment: a [<sup>11</sup>C]raclopride PET study in remitted first-episode psychosis patients
Franciska de Beer, Erik de Vries, Ben Wijnen, et al.
Plos One
|
July 19, 2019
"Please tell me what happened": A descriptive study on prevalence, disclosure and characteristics of victimization in people with a psychotic disorder
Bertine de Vries, Gerdina H M Pijnenborg, Elisabeth C D van der Stouwe, et al.
JAMA Psychiatry
|
October 1, 2025
Early Dose Reduction or Discontinuation vs Maintenance Antipsychotics After First Psychotic Episode Remission: A Randomized Clinical Trial
Iris E Sommer, Franciska de Beer, Shiral Gangadin, et al.
Schizophrenia Research
|
March 20, 2026
Genetic susceptibility of cardiometabolic outcomes in schizophrenia spectrum disorders
Chenxu Zhao, Bochao Lin, Elnaz Naderi, et al.
Nature Medicine
|
August 13, 2025
Virtual reality-based versus standard cognitive behavioral therapy for paranoia in schizophrenia spectrum disorders: a randomized controlled trial
Ulrik N Jeppesen, Ditte L Vernal, Anne Sofie Due, et al.
Pilot and Feasibility Studies
|
May 2, 2020
A cognitive remediation training for young adults with psychotic disorders to support their participation in education - study protocol for a pilot randomized controlled trial
Lana K M Otto, Jacomijn Hofstra, Michelle G Mullen, et al.
Page
of 16